Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms

被引：24

作者：

Halpern, Anna B. ^{[1
,2
]}

Othus, Megan ^{[3
]}

Huebner, Emily M. ^{[1
]}

Scott, Bart L. ^{[1
,4
]}

Hendrie, Paul C. ^{[2
]}

Percival, Mary-Elizabeth M. ^{[1
,2
]}

Becker, Pamela S. ^{[1
,2
]}

Smith, Heather A. ^{[5
]}

Oehler, Vivian G. ^{[1
,2
]}

Orozco, Johnnie J. ^{[1
,2
]}

Cassaday, Ryan D. ^{[1
,2
]}

Gardner, Kelda M. ^{[2
]}

Chen, Tara L. ^{[6
]}

Buckley, Sarah A. ^{[7
]}

Orlowski, Kaysey F. ^{[1
]}

Anwar, Asma ^{[7
]}

Estey, Elihu H. ^{[1
,2
]}

Walter, Roland B. ^{[1
,2
,8
]}

机构：

[1] Univ Washington, Clin Res Div, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA

[2] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA

[3] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA

[4] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USA

[5] Seattle Canc Care Alliance, Seattle, WA USA

[6] Univ Washington, Dept Pharm Serv, Seattle, WA 98195 USA

[7] Univ Washington, Fred Hutchinson Canc Res Ctr, Hematol Oncol Fellowship Program, Seattle, WA 98195 USA

[8] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA

来源：

HAEMATOLOGICA | 2019年 / 104卷 / 04期

基金：

美国国家卫生研究院;

关键词：

COLONY-STIMULATING FACTOR; EARLY DEATH; COMBINATION; CLOFARABINE; PREDICTION; ETOPOSIDE; ADULTS; RISK;

D O I：

10.3324/haematol.2018.204792

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E143 / E146

页数：4

共 11 条

[1] Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage therapies for acute myeloid leukemia [J].

Becker, Pamela S. ;

Kantarjian, Hagop M. ;

Appelbaum, Frederick R. ;

Storer, Barry ;

Pierce, Sherry ;

Shan, Jianqin ;

Faderl, Stephan ;

Estey, Elihu H. .

HAEMATOLOGICA, 2013, 98 (01) :114-118

[2] Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia [J].

Becker, Pamela S. ;

Kantarjian, Hagop M. ;

Appelbaum, Frederick R. ;

Petersdorf, Stephen H. ;

Storer, Barry ;

Pierce, Sherry ;

Shan, Jianqin ;

Hendrie, Paul C. ;

Pagel, John M. ;

Shustov, Andrei R. ;

Stirewalt, Derek L. ;

Faderl, Stephan ;

Harrington, Elizabeth ;

Estey, Elihu H. .

BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (02) :182-189

[3] Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study [J].

Chen, Tara L. ;

Estey, Elihu H. ;

Othus, Megan ;

Gardner, Kelda M. ;

Markle, Lauren J. ;

Walter, Roland B. .

LEUKEMIA & LYMPHOMA, 2013, 54 (11) :2534-2536

[4] Anthracycline Dose Intensification in Acute Myeloid Leukemia [J].

Fernandez, Hugo F. ;

Sun, Zhuoxin ;

Yao, Xiaopan ;

Litzow, Mark R. ;

Luger, Selina M. ;

Paietta, Elisabeth M. ;

Racevskis, Janis ;

Dewald, Gordon W. ;

Ketterling, Rhett P. ;

Bennett, John M. ;

Rowe, Jacob M. ;

Lazarus, Hillard M. ;

Tallman, Martin S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1249-1259

[5] Prediction of early death in adults with relapsed or refractory acute myeloid leukemia [J].

Godwin, Colin D. ;

Othus, Megan ;

Powell, Morgan A. ;

Buckley, Sarah A. ;

Estey, Elihu H. ;

Walter, Roland B. .

LEUKEMIA & LYMPHOMA, 2016, 57 (10) :2421-2424

[6] Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study [J].

Halpern, A. B. ;

Othus, M. ;

Huebner, E. M. ;

Buckley, S. A. ;

Pogosova-Agadjanyan, E. L. ;

Orlowski, K. F. ;

Scott, B. L. ;

Becker, P. S. ;

Hendrie, P. C. ;

Chen, T. L. ;

Percival, M-E M. ;

Estey, E. H. ;

Stirewalt, D. L. ;

Walter, R. B. .

LEUKEMIA, 2017, 31 (12) :2560-2567

[7] Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms [J].

Halpern, Anna B. ;

Othus, Megan ;

Huebner, Emily M. ;

Scott, Bart L. ;

Becker, Pamela S. ;

Percival, Mary-Elizabeth M. ;

Hendrie, Paul C. ;

Gardner, Kelda M. ;

Chen, Tara L. ;

Buckley, Sarah A. ;

Orlowski, Kaysey F. ;

Anwar, Asma ;

Appelbaum, Frederick R. ;

Erba, Harry P. ;

Estey, Elihu H. ;

Walter, Roland B. .

LEUKEMIA, 2018, 32 (11) :2352-2362

[8] High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia [J].

Lowenberg, Bob ;

Ossenkoppele, Gert J. ;

van Putten, Wim ;

Schouten, Harry C. ;

Graux, Carlos ;

Ferrant, Augustin ;

Sonneveld, Pieter ;

Maertens, Johan ;

Jongen-Lavrencic, Mojca ;

von Lilienfeld-Toal, Marie ;

Biemond, Bart J. ;

Vellenga, Edo ;

Kooy, Marinus van Marwijk ;

Verdonck, Leo F. ;

Beck, Joachim ;

Doehner, Hartmut ;

Gratwohl, Alois ;

Pabst, Thomas ;

Verhoef, Gregor .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1235-1248

[9] How I treat refractory and early relapsed acute myeloid leukemia [J].

Thol, Felicitas ;

Schlenk, Richard F. ;

Heuser, Michael ;

Ganser, Arnold .

BLOOD, 2015, 126 (03) :319-327

[10] Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment [J].

Walter, Roland B. ;

Othus, Megan ;

Borthakur, Gautam ;

Ravandi, Farhad ;

Cortes, Jorge E. ;

Pierce, Sherry A. ;

Appelbaum, Frederick R. ;

Kantarjian, Hagop A. ;

Estey, Elihu H. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) :4417-4423

← 1 2 →